Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis

Ming Han Li, Yueh Hsia Luo, Chiou Feng Lin, Yu Tzu Chang, Shiou Ling Lu, Chih Feng Kuo, Jau Shyong Hong, Yee Shin Lin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Group A streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, ranging from mild throat and skin infections to severe invasive diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), a dextrorotatory morphinan and a widely used antitussive drug, has recently been reported to possess anti-inflammatory properties. In this study, we investigated the potential protective effect of DM in GAS infection using an air pouch infection mouse model. Our results showed that DM treatment increased the survival rate of GAS-infected mice. Bacterial numbers in the air pouch were lower in mice treated with DM than in those infected with GAS alone. The bacterial elimination efficacy was associated with increased cell viability and bactericidal activity of air-pouch-infiltrating cells. Moreover, DM treatment prevented bacterial dissemination in the blood and reduced serum levels of the proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and IL-1β and the chemokines monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 2 (MIP-2), and RANTES. In addition, GAS-induced mouse liver injury was reduced by DM treatment. Taken together, DM can increase bacterial killing and reduce inflammatory responses to prevent sepsis in GAS infection. The consideration of DM as an adjunct treatment in combination with antibiotics against bacterial infection warrants further study.

Original languageEnglish
Pages (from-to)967-973
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume55
Issue number3
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Fingerprint

Dextromethorphan
Sepsis
Streptococcus
Air
Infection
Morphinans
Chemokine CXCL2
Antitussive Agents
Necrotizing Fasciitis
Chemokine CCL5
Chemokine CCL2
Septic Shock
Pharynx
Interleukin-1
Chemokines
Bacterial Infections
Interleukin-6
Cell Survival
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis. / Li, Ming Han; Luo, Yueh Hsia; Lin, Chiou Feng; Chang, Yu Tzu; Lu, Shiou Ling; Kuo, Chih Feng; Hong, Jau Shyong; Lin, Yee Shin.

In: Antimicrobial Agents and Chemotherapy, Vol. 55, No. 3, 03.2011, p. 967-973.

Research output: Contribution to journalArticle

Li, Ming Han ; Luo, Yueh Hsia ; Lin, Chiou Feng ; Chang, Yu Tzu ; Lu, Shiou Ling ; Kuo, Chih Feng ; Hong, Jau Shyong ; Lin, Yee Shin. / Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis. In: Antimicrobial Agents and Chemotherapy. 2011 ; Vol. 55, No. 3. pp. 967-973.
@article{9e996a5d82e04bab8da04aa61162fd6c,
title = "Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis",
abstract = "Group A streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, ranging from mild throat and skin infections to severe invasive diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), a dextrorotatory morphinan and a widely used antitussive drug, has recently been reported to possess anti-inflammatory properties. In this study, we investigated the potential protective effect of DM in GAS infection using an air pouch infection mouse model. Our results showed that DM treatment increased the survival rate of GAS-infected mice. Bacterial numbers in the air pouch were lower in mice treated with DM than in those infected with GAS alone. The bacterial elimination efficacy was associated with increased cell viability and bactericidal activity of air-pouch-infiltrating cells. Moreover, DM treatment prevented bacterial dissemination in the blood and reduced serum levels of the proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and IL-1β and the chemokines monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 2 (MIP-2), and RANTES. In addition, GAS-induced mouse liver injury was reduced by DM treatment. Taken together, DM can increase bacterial killing and reduce inflammatory responses to prevent sepsis in GAS infection. The consideration of DM as an adjunct treatment in combination with antibiotics against bacterial infection warrants further study.",
author = "Li, {Ming Han} and Luo, {Yueh Hsia} and Lin, {Chiou Feng} and Chang, {Yu Tzu} and Lu, {Shiou Ling} and Kuo, {Chih Feng} and Hong, {Jau Shyong} and Lin, {Yee Shin}",
year = "2011",
month = "3",
doi = "10.1128/AAC.00950-10",
language = "English",
volume = "55",
pages = "967--973",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis

AU - Li, Ming Han

AU - Luo, Yueh Hsia

AU - Lin, Chiou Feng

AU - Chang, Yu Tzu

AU - Lu, Shiou Ling

AU - Kuo, Chih Feng

AU - Hong, Jau Shyong

AU - Lin, Yee Shin

PY - 2011/3

Y1 - 2011/3

N2 - Group A streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, ranging from mild throat and skin infections to severe invasive diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), a dextrorotatory morphinan and a widely used antitussive drug, has recently been reported to possess anti-inflammatory properties. In this study, we investigated the potential protective effect of DM in GAS infection using an air pouch infection mouse model. Our results showed that DM treatment increased the survival rate of GAS-infected mice. Bacterial numbers in the air pouch were lower in mice treated with DM than in those infected with GAS alone. The bacterial elimination efficacy was associated with increased cell viability and bactericidal activity of air-pouch-infiltrating cells. Moreover, DM treatment prevented bacterial dissemination in the blood and reduced serum levels of the proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and IL-1β and the chemokines monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 2 (MIP-2), and RANTES. In addition, GAS-induced mouse liver injury was reduced by DM treatment. Taken together, DM can increase bacterial killing and reduce inflammatory responses to prevent sepsis in GAS infection. The consideration of DM as an adjunct treatment in combination with antibiotics against bacterial infection warrants further study.

AB - Group A streptococcus (GAS) is an important human pathogen that causes a wide spectrum of diseases, ranging from mild throat and skin infections to severe invasive diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome. Dextromethorphan (DM), a dextrorotatory morphinan and a widely used antitussive drug, has recently been reported to possess anti-inflammatory properties. In this study, we investigated the potential protective effect of DM in GAS infection using an air pouch infection mouse model. Our results showed that DM treatment increased the survival rate of GAS-infected mice. Bacterial numbers in the air pouch were lower in mice treated with DM than in those infected with GAS alone. The bacterial elimination efficacy was associated with increased cell viability and bactericidal activity of air-pouch-infiltrating cells. Moreover, DM treatment prevented bacterial dissemination in the blood and reduced serum levels of the proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and IL-1β and the chemokines monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 2 (MIP-2), and RANTES. In addition, GAS-induced mouse liver injury was reduced by DM treatment. Taken together, DM can increase bacterial killing and reduce inflammatory responses to prevent sepsis in GAS infection. The consideration of DM as an adjunct treatment in combination with antibiotics against bacterial infection warrants further study.

UR - http://www.scopus.com/inward/record.url?scp=79952321922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952321922&partnerID=8YFLogxK

U2 - 10.1128/AAC.00950-10

DO - 10.1128/AAC.00950-10

M3 - Article

VL - 55

SP - 967

EP - 973

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -